Literature DB >> 2432587

Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain.

T V Dam, R Quirion.   

Abstract

[3H]Substance P ([3H]SP) was used to characterize substance P (SP) receptor binding sites in guinea pig brain using membrane preparations and in vitro receptor autoradiography. Curvilinear Scatchard analysis shows that [3H]SP binds to a high affinity site (Kd = 0.5 nM) with a Bmax of 16.4 fmol/mg protein and a low affinity site (Kd = 29.6 nM) with a Bmax of 189.1 fmol/mg protein. Monovalent cations generally inhibit [3H]SP binding while divalent cations substantially increased it. The ligand selectivity pattern is generally similar to the one observed in rat brain membrane preparation with SP being more potent than SP fragments and other tachykinins. However, the potency of various nucleotides is different with GMP-PNP greater than GDP greater than GTP. The autoradiographic distribution of [3H]SP binding sites shows that high amounts of sites are present in the hippocampus, striatum, olfactory bulb, central nucleus of the amygdala, certain thalamic nuclei and superior colliculus. The cortex is moderately enriched in [3H]SP binding sites while the substantia nigra contains only very low amounts of sites. Thus, the autoradiographic distribution of SP binding sites is fairly similar in both rat and guinea pig brain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2432587     DOI: 10.1016/0196-9781(86)90106-3

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.

Authors:  I J Beresford; P J Birch; R M Hagan; S J Ireland
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

2.  The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.

Authors:  D T Beattie; I J Beresford; H E Connor; F H Marshall; A B Hawcock; R M Hagan; J Bowers; P J Birch; P Ward
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

Review 4.  The role of neurokinin-1 receptor in the microenvironment of inflammation and cancer.

Authors:  Marisa Rosso; Miguel Muñoz; Michael Berger
Journal:  ScientificWorldJournal       Date:  2012-04-01

Review 5.  Substance P Regulation in Epilepsy.

Authors:  Guangfan Chi; Zhehao Huang; Xianglan Li; Kun Zhang; Guangquan Li
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.

Authors:  Kate Marie Lewis; Renée Jade Turner; Robert Vink
Journal:  Int J Inflam       Date:  2013-05-29

7.  The role of substance p in ischaemic brain injury.

Authors:  Renée J Turner; Robert Vink
Journal:  Brain Sci       Date:  2013-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.